First-in-human study of a new injection (HEC-151)
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old.
- You weigh at least 110 pounds (50 kg) and have a healthy BMI (19 to 24).
- Your blood sugar is normal (not diabetic or pre-diabetic).
- You have no major health problems, allergies, or recent surgeries.
- You do not smoke heavily, drink a lot, or use recreational drugs.
- You are willing to avoid pregnancy during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single injection of a new enzyme (called recombinant human hyaluronidase) is safe in healthy men. It helps break down a substance in the body, potentially making other injected medicines work better, but this study only checks safety and how the body handles it.
This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.
This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
Hear when a new Healthy Adult Male trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.